15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer
Introduction
Locally advanced non-small cell lung carcinoma (NSCLSC), with invasion of the superior vena cava (SVC), defined as Stage IIIb (TNM classification), is generally considered a contraindication for surgery. Early reports demonstrated no long-term survivors among T4 patients who underwent surgical resection [1]. Yet, over the last 15 years, several reports regarding surgical resection for selected T4 tumors have shown better results, with acceptable peri-operative morbidity, and 5-year survival of up to 30% [2], [3], [4], [5].
It has also been suggested, that among patients with T4 tumors, those with SVC invasion may have a better prognosis, when the tumor is surgically resected, as compared to those with tumors invading the esophagus, myocardium or aorta [3], [6].
The purpose of this study was to review our experience in this selected group of patients. We retrospectively analyzed our results with patients who underwent resection for NSCLC with direct SVC involvement by the tumor, emphasizing immediate and long-term survival, and defining factors that might influence survival.
Section snippets
Patients and methods
From February 1988 through August 2003, 23 patients underwent SVC resection for thoracic malignancies with direct SVC involvement by tumor. Patient with SVC invaded by mediastinal lymph nodes (and not by the tumor itself), as well as patients with evidence of distal metastases were not included in this study. Hospital charts, operative notes and pathology reports were reviewed after approval by the University Health Network Research Ethics Board. Follow-up was obtained through Thoracic Surgery
Results
There were nine males and six females. The median age was 60 years, ranging from 28 to 78 (Table 1). Follow-up was complete in all but one patient. This patient was alive and free of disease more than 11 years after right pneumonectomy for T4N2 disease, but was lost to follow-up thereafter. Mean follow-up time was 25 months, ranging from 3 to 132 months (median 11 months). All patients had proven NSCLC prior to any treatment.
There were seven patients with squamous cell carcinoma, five with
Comment
Surgical resection of locally advanced (T4) NSC lung cancer has traditionally been considered a surgical contraindication, as this group of patients had previously experienced an overall 5-year survival of 6–8% [7]. Initial reports regarding patients with NSCLC and direct SVC invasion revealed only anecdotal long-term survivors, and were usually published as case reports [8], [9]. The Memorial Sloan–Kettering Cancer Center group was among the first to report experience with a series of
References (16)
- et al.
Results of surgical treatment of stage III lung cancer invading the mediastinum
Surg. Clin. North Am.
(1987) - et al.
Long-term follow-up after prosthetic replacement of the superior vena cava combined with the resection of mediastinal-pulmonary malignant tumors
J. Thorac. Cardiovasc. Surg.
(1991) - et al.
Extended operations after induction therapy for stage IIIb(T4) non-small cell lung cancer
Ann. Thorac. Surg.
(1994) - et al.
Extended resections for bronchogenic carcinoma invading the superior vena cava system
Ann. Thorac. Surg.
(2000) - et al.
Management of non-small cell lung cancer with direct mediastinal involvement
Ann. Thorac. Surg.
(1994) - et al.
Resection of the superior vena cava for primary lung cancer: 5 years’ survivar
Ann. Thorac. Surg.
(1990) - et al.
Surgical treatment for higher stage non-small cell lung cancer
Ann. Thorac. Surg.
(1992) - et al.
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroup: long-term results
Ann. Thorac. Surg.
(1999)